Exelixis is a biopharmaceutical company committed to developing and commercializing small molecule therapies for the treatment of cancer. In advancing...
The investment objective of the Dow 30SM Premium & Dividend Income Fund is to provide stockholders with a high level...
Philippos Nakas SA
19th klm. Lavriou Avenue Attiki
SIC Code: 5736